A detailed history of Griffith & Werner, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Griffith & Werner, Inc. holds 2,005 shares of ABT stock, worth $260,710. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,005
Previous 2,082 3.7%
Holding current value
$260,710
Previous $276 Million 8.61%
% of portfolio
0.13%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$120.51 - $136.62 $9,279 - $10,519
-77 Reduced 3.7%
2,005 $252 Million
Q1 2025

Apr 14, 2025

BUY
$111.1 - $140.22 $222 - $280
2 Added 0.1%
2,082 $276 Million
Q4 2024

Feb 20, 2025

BUY
$111.93 - $119.39 $232,814 - $248,331
2,080 New
2,080 $235 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Griffith & Werner, Inc. Portfolio

Follow Griffith & Werner, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffith & Werner, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffith & Werner, Inc. with notifications on news.